Tarhini AA - Search Results

1

Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis.

Tawbi HA, Beumer JH, Tarhini AA, Moschos S, Buch SC, Egorin MJ, Lin Y, Christner S, Kirkwood JM. Tawbi HA, et al. Among authors: tarhini aa. Ann Oncol. 2013 Apr;24(4):1112-9. doi: 10.1093/annonc/mds591. Epub 2012 Nov 21. Ann Oncol. 2013. PMID: 23172636 Free PMC article. Clinical Trial.

2

Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy.

Kirkwood JM, Bender C, Agarwala S, Tarhini A, Shipe-Spotloe J, Smelko B, Donnelly S, Stover L. Kirkwood JM, et al. J Clin Oncol. 2002 Sep 1;20(17):3703-18. doi: 10.1200/JCO.2002.03.052. J Clin Oncol. 2002. PMID: 12202672 Review.

3

Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.

Kirkwood JM, Tarhini AA. Kirkwood JM, et al. Among authors: tarhini aa. Forum (Genova). 2003;13(2):127-40; quiz 187-8. Forum (Genova). 2003. PMID: 14732880 Review.

4

Management of brain metastases in patients with melanoma.

Tarhini AA, Agarwala SS. Tarhini AA, et al. Curr Opin Oncol. 2004 Mar;16(2):161-6. doi: 10.1097/00001622-200403000-00014. Curr Opin Oncol. 2004. PMID: 15075910 Review.

5

Does childhood vaccination and exposure to infection improve long-term survival in patients with malignant melanoma?

Tarhini AA, Land S, Gupta A, Kirkwood JM. Tarhini AA, et al. Nat Clin Pract Oncol. 2005 May;2(5):240-1. doi: 10.1038/ncponc0175. Nat Clin Pract Oncol. 2005. PMID: 16264957 No abstract available.

6

Interleukin-2 for the treatment of melanoma.

Tarhini AA, Agarwala SS. Tarhini AA, et al. Curr Opin Investig Drugs. 2005 Dec;6(12):1234-9. Curr Opin Investig Drugs. 2005. PMID: 16370388 Review.

7

Cutaneous melanoma: available therapy for metastatic disease.

Tarhini AA, Agarwala SS. Tarhini AA, et al. Dermatol Ther. 2006 Jan-Feb;19(1):19-25. doi: 10.1111/j.1529-8019.2005.00052.x. Dermatol Ther. 2006. PMID: 16405566 Review.

8

Response to "helping melanoma patients decide whether to choose adjuvant high-dose interferon-alpha2b".

Tarhini AA, Shipe-Spotloe J, DeMark M, Agarwala SS, Kirkwood JM. Tarhini AA, et al. Oncologist. 2006 May;11(5):538-9; author reply 539-40. doi: 10.1634/theoncologist.11-5-538. Oncologist. 2006. PMID: 16720861 Free article. No abstract available.

9

Oblimersen in the treatment of metastatic melanoma.

Tarhini AA, Kirkwood JM. Tarhini AA, et al. Future Oncol. 2007 Jun;3(3):263-71. doi: 10.2217/14796694.3.3.263. Future Oncol. 2007. PMID: 17547520 Review.

10

Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy.

Tarhini AA, Kirkwood JM, Gooding WE, Cai C, Agarwala SS. Tarhini AA, et al. J Clin Oncol. 2007 Sep 1;25(25):3802-7. doi: 10.1200/JCO.2006.10.2822. J Clin Oncol. 2007. PMID: 17761969 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters